| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $256.2M | +18.4% |
| Cost of Revenue | $64.7M | +48.4% |
| Gross Profit | $191.5M | +10.8% |
| R&D Expense | $27.1M | -10.0% |
| SG&A Expense | $205.2M | +14.0% |
| Operating Income | -$40.8M | -9.3% |
| Pre-tax Income | -$53.5M | -12.3% |
| Income Tax | $1.2M | +444.1% |
| Net Income | -$54.6M | -14.2% |
| EPS (Basic) | -$0.66 | -13.8% |
| EPS (Diluted) | -$0.66 | -13.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $34.6M | -54.3% |
| Accounts Receivable | $39.0M | +4.5% |
| Inventory | $90.0M | -8.2% |
| Current Assets | $168.8M | -21.8% |
| Total Assets | $290.7M | -14.7% |
| Current Liabilities | $48.1M | -6.1% |
| Long-term Debt | $110.7M | +0.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$27.1M | +57.5% |
| Investing Cash Flow | -$15.7M | +41.9% |
| Financing Cash Flow | $293K | -99.8% |
| Total Liabilities |
| $160.1M |
| -1.7% |
| Stockholders' Equity | $130.6M | -26.5% |